The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction
Abstract
Background—: Ticagrelor and prasugrel provide stronger platelet inhibition compared with clopidogrel. Direct pharmacodynamic comparison between them has not yet been reported in ST-segment–elevation myocardial infarction patients. Methods and Results—: In a prospective, single-center, single-blind study, 55 out of 117 (47%) screened consecutive ST-segment–elevation myocardial infarction patients undergoing primary percutaneous coronary intervention were randomized to either ticagrelor 180 mg loading followed by 90 mg bid, or prasugrel 60 mg loading followed by 10 mg od for 5 days. Platelet reactivity (PR) was assessed with the VerifyNow P2Y12 function assay and the Multiplate Analyzer at 0, 1, 2, 6, 24 hours, and 5 days postrandomization. The primary end point, PR with VerifyNow at hour 1, did not differ significantly between patients randomized to ticagrelor versus prasugrel (257.3 P2Y12 reaction unit [PRU], 95% CI 230.8–283.8 versus 231.3 PRU, 95% CI 205.3–257.4; P =0.2). PR did not differ at 2, 6, and 24 hours, although at day 5 it was lower with ticagrelor than prasugrel (25.6 PRU, 95% CI 12.3–38.9 versus 50.3 PRU, 95% CI 36.4–64.1; P =0.01). At hour 2, high on-treatment PR rates (cutoff 208 PRU) were 46.2% and 34.6% for ticagrelor and prasugrel, respectively, decreased significantly thereafter, whereas did not differ significantly between the 2 agents at all the time points of the study. Conclusions—: In patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention, both ticagrelor and prasugrel exhibit an initial delay in the onset of their antiplatelet action. Ticagrelor did not appear superior to prasugrel in reducing PR during the first 24 hours of ST-segment–elevation myocardial infarction. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01463163.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Self-citation2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Gurbel, P. A., Bliden, K. P., Butler, K., Tantry, U. S., Gesheff, T., Wei, C., Teng, R., Antonino, M. J., Patil, S. B., Karunakaran, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.912550 · Cited by 1,159
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,149
Montalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., & Antman, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60441-4 · Cited by 1,068
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
Wiviott, S. D., Trenk, D., Frelinger, A. L., O’Donoghue, M., Neumann, F.-J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.740324 · Cited by 881
Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., Husted, S., Katus, H., Steg, P. G., Shah, S. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61274-3 · Cited by 799
Steg, P. G., James, S., Harrington, R. A., Ardissino, D., Becker, R. C., Cannon, C. P., Emanuelsson, H., Finkelstein, A., Husted, S., Katus, H., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927582 · Cited by 507
Wallentin, L., Varenhorst, C., James, S., Erlinge, D., Braun, O. O., Jakubowski, J. A., Sugidachi, A., Winters, K. J., & Siegbahn, A. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm545 · Cited by 457
Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention
Brar, S. S., ten Berg, J., Marcucci, R., Price, M. J., Valgimigli, M., Kim, H.-S., Patti, G., Breet, N. J., DiSciascio, G., Cuisset, T., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.059 · Cited by 422
Price, M. J., Angiolillo, D. J., Teirstein, P. S., Lillie, E., Manoukian, S. V., Berger, P. B., Tanguay, J.-F., Cannon, C. P., & Topol, E. J. (2011) · Circulation · doi:10.1161/circulationaha.111.029165 · Cited by 396
Storey, R. F., Angiolillo, D. J., Patil, S. B., Desai, B., Ecob, R., Husted, S., Emanuelsson, H., Cannon, C. P., Becker, R. C., & Wallentin, L. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.100 · Cited by 373
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty
Gawaz, M., Neumann, F.-J., Ott, I., Schiessler, A., & Schömig, A. (1996) · Circulation · doi:10.1161/01.cir.93.2.229 · Cited by 302
Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
Teng, R., Oliver, S., Hayes, M. A., & Butler, K. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032250 · Cited by 264
Michelson, A. D., Frelinger, A. L., Braunwald, E., Downey, W. E., Angiolillo, D. J., Xenopoulos, N. P., Jakubowski, J. A., Li, Y., Murphy, S. A., Qin, J., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp159 · Cited by 257
Bonello, L., Pansieri, M., Mancini, J., Bonello, R., Maillard, L., Barnay, P., Rossi, P., Ait-Mokhtar, O., Jouve, B., Collet, F., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.017 · Cited by 209
Teng, R., & Butler, K. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0778-5 · Cited by 196
Alexopoulos, D., Galati, A., Xanthopoulou, I., Mavronasiou, E., Kassimis, G., Theodoropoulos, K. C., Makris, G., Damelou, A., Tsigkas, G., Hahalis, G., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.050 · Cited by 193
Self-citationAngiolillo, D. J., Badimon, J. J., Saucedo, J. F., Frelinger, A. L., Michelson, A. D., Jakubowski, J. A., Zhu, B., Ojeh, C. K., Baker, B. A., & Effron, M. B. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq494 · Cited by 183
Valgimigli, M., Tebaldi, M., Campo, G., Gambetti, S., Bristot, L., Monti, M., Parrinello, G., & Ferrari, R. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.01.006 · Cited by 173
Heestermans, A. A. C. M., van Werkum, J. W., Taubert, D., Seesing, T. H., von Beckerath, N., Hackeng, C. M., Schömig, E., Verheugt, F. W. A., & ten Berg, J. M. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.01.021 · Cited by 172
Campo, G. C., Valgimigli, M., Gemmati, D., Percoco, G., Tognazzo, S., Cicchitelli, G., Catozzi, L., Malagutti, P., Anselmi, M., Vassanelli, C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.085 · Cited by 138
Bliden, K. P., Tantry, U. S., Storey, R. F., Jeong, Y., Gesheff, M. G., Wei, C., & Gurbel, P. A. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.025 · Cited by 84
Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor
Giorgi, M. A., Arazi, H. C., González, C. D., & Girolamo, G. D. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.550573 · Cited by 56
Alexopoulos, D. K. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.088 · Cited by 19
Self-citation
Cited by
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Diener, H.-C., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2015) · Europace · doi:10.1093/europace/euv309 · Cited by 1,113
Tantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y.-H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., ten Berg, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.101 · Cited by 910
Self-citationEffect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events
Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300815 · Cited by 840
Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
Montalescot, G., van 't Hof, A. W., Lapostolle, F., Silvain, J., Lassen, J. F., Bolognese, L., Cantor, W. J., Cequier, Á., Chettibi, M., Goodman, S. G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407024 · Cited by 661
Bivalirudin Started during Emergency Transport for Primary PCI
Steg, P. G., van 't Hof, A., Hamm, C. W., Clemmensen, P., Lapostolle, F., Coste, P., Ten Berg, J., Van Grunsven, P., Eggink, G. J., Nibbe, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311096 · Cited by 498
Metadata
- Authors
- Alexopoulos, D., Xanthopoulou, I., Gkizas, V., Kassimis, G., Theodoropoulos, K. C., Makris, G., Koutsogiannis, N., Damelou, A., Tsigkas, G., Davlouros, P., & Hahalis, G.
- Venue
- Circulation: Cardiovascular Interventions
- Published
- 2012-12
- Volume
- 5
- Issue
- 6
- Pages
- 797-804
- ISSN
- 1941-7632 (ISSN-L)
- 1941-7640
- OpenAlex
- W2153447053
- Cited by
- 396
- References
- 30
- FWCI
- 32.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.